SA515370167B1 - نظام ضمادة لتوليد أكسيد النيتريك - Google Patents

نظام ضمادة لتوليد أكسيد النيتريك

Info

Publication number
SA515370167B1
SA515370167B1 SA515370167A SA515370167A SA515370167B1 SA 515370167 B1 SA515370167 B1 SA 515370167B1 SA 515370167 A SA515370167 A SA 515370167A SA 515370167 A SA515370167 A SA 515370167A SA 515370167 B1 SA515370167 B1 SA 515370167B1
Authority
SA
Saudi Arabia
Prior art keywords
nitric oxide
dressing system
oxide generating
generating dressing
hydrogel
Prior art date
Application number
SA515370167A
Other languages
Arabic (ar)
English (en)
Inventor
تودور توكير ارثر
الين ستيوارت جوان
باري وود كريستوفر
ديفيد بووت نيكولاس
سيمبل مونرو هوج
Original Assignee
اديكسوميد ليمتد
فريست واتير ليمتد
كوين ماري يونفيرستي اوف لندن
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اديكسوميد ليمتد, فريست واتير ليمتد, كوين ماري يونفيرستي اوف لندن filed Critical اديكسوميد ليمتد
Publication of SA515370167B1 publication Critical patent/SA515370167B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SA515370167A 2013-05-20 2015-11-19 نظام ضمادة لتوليد أكسيد النيتريك SA515370167B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1309091.5A GB201309091D0 (en) 2013-05-20 2013-05-20 Dressing system
PCT/GB2014/051543 WO2014188174A1 (en) 2013-05-20 2014-05-20 Dressing system

Publications (1)

Publication Number Publication Date
SA515370167B1 true SA515370167B1 (ar) 2017-10-05

Family

ID=48747064

Family Applications (1)

Application Number Title Priority Date Filing Date
SA515370167A SA515370167B1 (ar) 2013-05-20 2015-11-19 نظام ضمادة لتوليد أكسيد النيتريك

Country Status (17)

Country Link
US (1) US9662414B2 (cg-RX-API-DMAC7.html)
EP (1) EP2908872B1 (cg-RX-API-DMAC7.html)
JP (1) JP6559655B2 (cg-RX-API-DMAC7.html)
CN (1) CN105579074B (cg-RX-API-DMAC7.html)
AU (1) AU2014270115B2 (cg-RX-API-DMAC7.html)
DK (1) DK2908872T3 (cg-RX-API-DMAC7.html)
ES (1) ES2661643T3 (cg-RX-API-DMAC7.html)
GB (1) GB201309091D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20180275T1 (cg-RX-API-DMAC7.html)
HU (1) HUE038361T2 (cg-RX-API-DMAC7.html)
LT (1) LT2908872T (cg-RX-API-DMAC7.html)
NO (1) NO2908872T3 (cg-RX-API-DMAC7.html)
PL (1) PL2908872T3 (cg-RX-API-DMAC7.html)
PT (1) PT2908872T (cg-RX-API-DMAC7.html)
RS (1) RS56954B1 (cg-RX-API-DMAC7.html)
SA (1) SA515370167B1 (cg-RX-API-DMAC7.html)
WO (1) WO2014188174A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201309092D0 (en) * 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
GB201520990D0 (en) 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
US11506658B2 (en) 2019-04-24 2022-11-22 Progenitec, Inc. System for analysis of body fluids and wound-associated biomolecules
BR112021023832A8 (pt) 2019-06-04 2023-02-28 Thirty Holdings Ltd Métodos e composições para geração de óxido nítrico e usos dos mesmos
JP7686578B2 (ja) 2019-06-04 2025-06-02 サーティー レスピラトリー リミテッド 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
BR112021025291A2 (pt) * 2019-06-12 2022-05-10 Sanotize Res And Development Corp Dispositivos de contenção de medicamento e composições associadas
EP4126087A1 (en) 2020-04-02 2023-02-08 T.J.Smith and Nephew,Limited Wound dressing control and activation
GB202004868D0 (en) * 2020-04-02 2020-05-20 Smith & Nephew Wound care compositions and methods of preparation thereof
AU2021259360A1 (en) 2020-04-23 2022-12-01 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating SARS-CoV and SARS-CoV-2
CN115768413B (zh) 2020-04-23 2025-10-24 三十呼吸有限公司 用于治疗及抗击结核病的方法和组合物
CN113101053A (zh) * 2021-03-30 2021-07-13 上海健康医学院 一种可释放一氧化氮的创伤敷料
WO2022268369A1 (de) 2021-06-23 2022-12-29 Beiersdorf Ag Hautabdeckung, zur erhöhung der no konzentration in der haut
GB202114294D0 (en) * 2021-10-06 2021-11-17 Smith & Nephew Wound dressing apparatuses and methods for nitric oxide delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002521526A (ja) * 1998-07-31 2002-07-16 ファースト ウォーター リミテッド 疎水性ポリマーを含む生体接着剤組成物
GB9905425D0 (en) 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
CA2323382C (en) * 2000-10-17 2004-04-13 Pharma Mag Inc. Wound dressing
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
GB0715554D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US20100055161A1 (en) * 2008-08-27 2010-03-04 Dong June Ahn Hydrogel face mask for delivering skin care agents
WO2011076216A2 (en) * 2009-12-22 2011-06-30 Rigshospitalet, Copenhagen University Hospital Wound care products

Also Published As

Publication number Publication date
US20160082142A1 (en) 2016-03-24
PT2908872T (pt) 2018-03-08
RS56954B1 (sr) 2018-05-31
LT2908872T (lt) 2018-03-12
NO2908872T3 (cg-RX-API-DMAC7.html) 2018-04-14
HUE038361T2 (hu) 2018-10-29
JP6559655B2 (ja) 2019-08-14
EP2908872A1 (en) 2015-08-26
ES2661643T3 (es) 2018-04-02
JP2016522829A (ja) 2016-08-04
AU2014270115A1 (en) 2015-12-03
CN105579074B (zh) 2018-04-10
CN105579074A (zh) 2016-05-11
WO2014188174A1 (en) 2014-11-27
PL2908872T3 (pl) 2018-06-29
GB201309091D0 (en) 2013-07-03
DK2908872T3 (en) 2018-02-26
US9662414B2 (en) 2017-05-30
AU2014270115B2 (en) 2017-12-21
HRP20180275T1 (hr) 2018-04-20
EP2908872B1 (en) 2017-11-15

Similar Documents

Publication Publication Date Title
SA515370167B1 (ar) نظام ضمادة لتوليد أكسيد النيتريك
PH12020551397A1 (en) Cot modulators and methods of use thereof
MX357710B (es) Metodos y dispositivos para terapia de heridas.
EP2953538A4 (en) OXYGEN MASK AND CONSTITUENT SYSTEM
MX2015012326A (es) Anticuerpos anti-crth2 y su uso.
AU357122S (en) Headgear for patient interface
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
EP3032027A4 (en) Hydrogen supply system and hydrogen supply method
PL3069375T3 (pl) Koncentryczne źródło jonów, jonowód i sposób stosowania w jonizacji powierzchniowej APCI
GB201413104D0 (en) Use of ancillary devices in radiotherapy systems
EP2969132A4 (en) Hydrogen generation assemblies and hydrogen purification devices
EP3017089A4 (en) Hydrogen system and method of operation
EP3046987B8 (en) Use of organophosphorus containing composites for use in well treatment operations
IL240133A0 (en) A system for distributing quantum cryptograph keys that includes two peripheral devices and an optical source
IN2014DE01083A (cg-RX-API-DMAC7.html)
MY167656A (en) Absorbent body and absorbent article comprising absorbent body
MX2017017124A (es) 6-amino-quinolin-3-carbonitrilos como moduladores de cancer osaka tiroides (cot).
PH12016500598A1 (en) Protoxin-ii variants and methods of use
PH12016501173A1 (en) Quinazolin-thf-amines as pde1 inhibitors
GB2525778A (en) Context aware power management for graphics devices
MX2016004573A (es) Inhibidores de nsp4 y metodos de uso.
NZ711523A (en) Use of sedoheptulose for prevention or treatment of inflammation
LT2941233T (lt) Odos t-ląstelių limfomos gydymo kompozicija ir būdas
PH12016500541A1 (en) Use of odiparcil in the treatment of a mucopolysaccharidosis
MX2015010789A (es) Anticuerpos anti-pcsm.